Northwestern Mutual Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $835K | Sell |
11,123
-875
| -7% | -$69.1K | ﹤0.01% | 1405 |
|
|
2025
Q4 | $949K | Sell |
11,998
-784
| -6% | -$59K | ﹤0.01% | 1297 |
|
|
2025
Q3 | $836K | Buy |
12,782
+538
| +4% | +$26.3K | ﹤0.01% | 1293 |
|
|
2025
Q2 | $484K | Sell |
12,244
-114
| -0.9% | -$3.73K | ﹤0.01% | 1396 |
|
|
2025
Q1 | $373K | Buy |
12,358
+1,031
| +9% | +$33.8K | ﹤0.01% | 1438 |
|
|
2024
Q4 | $396K | Buy |
11,327
+64
| +0.6% | +$2.39K | ﹤0.01% | 1405 |
|
|
2024
Q3 | $451K | Buy |
11,263
+50
| +0.4% | +$2.33K | ﹤0.01% | 1342 |
|
|
2024
Q2 | $534K | Buy |
11,213
+67
| +0.6% | +$2.75K | ﹤0.01% | 1229 |
|
|
2024
Q1 | $483K | Hold |
11,146
| – | – | ﹤0.01% | 1259 |
|
|
2023
Q4 | $564K | Sell |
11,146
-21
| -0.2% | -$1.01K | ﹤0.01% | 1160 |
|
|
2023
Q3 | $507K | Buy |
11,167
+4,522
| +68% | +$187K | ﹤0.01% | 1152 |
|
|
2023
Q2 | $273K | Sell |
6,645
-257
| -4% | -$9.88K | ﹤0.01% | 1362 |
|
|
2023
Q1 | $247K | Sell |
6,902
-15
| -0.2% | -$563 | ﹤0.01% | 1368 |
|
|
2022
Q4 | $261K | Sell |
6,917
-330
| -5% | -$13.9K | ﹤0.01% | 1330 |
|
|
2022
Q3 | $320K | Buy |
7,247
+268
| +4% | +$11.3K | ﹤0.01% | 1226 |
|
|
2022
Q2 | $258K | Buy |
6,979
+4,716
| +208% | +$178K | ﹤0.01% | 1306 |
|
|
2022
Q1 | $83K | Buy |
2,263
+307
| +16% | +$10K | ﹤0.01% | 1787 |
|
|
2021
Q4 | $60K | Sell |
1,956
-56
| -3% | -$1.76K | ﹤0.01% | 1913 |
|
|
2021
Q3 | $68K | Buy |
2,012
+484
| +32% | +$18.2K | ﹤0.01% | 1787 |
|
|
2021
Q2 | $61K | Sell |
1,528
-411
| -21% | -$16.1K | ﹤0.01% | 1780 |
|
|
2021
Q1 | $86K | Buy |
1,939
+694
| +56% | +$38.7K | ﹤0.01% | 1546 |
|
|
2020
Q4 | $70K | Buy |
1,245
+14
| +1% | +$698 | ﹤0.01% | 1536 |
|
|
2020
Q3 | $59K | Buy |
1,231
+225
| +22% | +$12.5K | ﹤0.01% | 1445 |
|
|
2020
Q2 | $59K | Sell |
1,006
-512
| -34% | -$28.5K | ﹤0.01% | 1396 |
|
|
2020
Q1 | $71K | Buy |
1,518
+623
| +70% | +$34.7K | ﹤0.01% | 1244 |
|
|
2019
Q4 | $55K | Sell |
895
-669
| -43% | -$39.9K | ﹤0.01% | 1434 |
|
|
2019
Q3 | $93K | Buy |
1,564
+6
| +0.4% | +$391 | ﹤0.01% | 1187 |
|
|
2019
Q2 | $100K | Buy |
1,558
+73
| +5% | +$5.16K | ﹤0.01% | 1121 |
|
|
2019
Q1 | $121K | Buy |
1,485
+160
| +12% | +$10.3K | ﹤0.01% | 1013 |
|
|
2018
Q4 | $72K | Sell |
1,325
-4
| -0.3% | -$204 | ﹤0.01% | 1107 |
|
|
2018
Q3 | $69K | Sell |
1,329
-133
| -9% | -$6.25K | ﹤0.01% | 1175 |
|
|
2018
Q2 | $61K | Hold |
1,462
| – | – | ﹤0.01% | 1168 |
|
|
2018
Q1 | $64K | Buy |
1,462
+660
| +82% | +$33.5K | ﹤0.01% | 1103 |
|
|
2017
Q4 | $40K | Sell |
802
-6
| -0.7% | -$329 | ﹤0.01% | 1236 |
|
|
2017
Q3 | $41K | Buy |
808
+349
| +76% | +$18.3K | ﹤0.01% | 1200 |
|
|
2017
Q2 | $23K | Buy |
459
+29
| +7% | +$1.35K | ﹤0.01% | 1338 |
|
|
2017
Q1 | $17K | Sell |
430
-508
| -54% | -$22.8K | ﹤0.01% | 1393 |
|
|
2016
Q4 | $45K | Buy |
+938
| New | +$37.1K | ﹤0.01% | 1063 |
|
|
2016
Q3 | – | Sell |
-1,622
| Closed | -$38K | – | 831 |
|
|
2016
Q2 | $38K | Buy |
1,622
+205
| +14% | +$6.61K | ﹤0.01% | 977 |
|
|
2016
Q1 | $57K | Buy |
1,417
+666
| +89% | +$27.1K | ﹤0.01% | 854 |
|
|
2015
Q4 | $47K | Buy |
751
+369
| +97% | +$19.9K | ﹤0.01% | 800 |
|
|
2015
Q3 | $15K | Hold |
382
| – | – | ﹤0.01% | 1000 |
|
|
2015
Q2 | $22K | Buy |
382
+238
| +165% | +$15.1K | ﹤0.01% | 852 |
|
|
2015
Q1 | $9K | Buy |
144
+98
| +213% | +$6.65K | ﹤0.01% | 1062 |
|
|
2014
Q4 | $3K | Buy |
+46
| New | +$2.27K | ﹤0.01% | 1415 |
|
|
2014
Q1 | – | Sell |
-50
| Closed | -$2K | – | 1363 |
|
|
2013
Q4 | $2K | Buy |
+50
| New | +$1.78K | ﹤0.01% | 1243 |
|
Other funds holding IONS
VPM
VCM
Northwestern Mutual Wealth Management's IONS Position: Q1 2026 in Review
Northwestern Mutual Wealth Management reduced its Ionis Pharmaceuticals (IONS) stake by 7.3% in Q1 2026, selling an estimated $69.1K and leaving 11,123 shares worth $835K. The position accounts for ﹤0.01% of the portfolio, ranked #1405.
Northwestern Mutual Wealth Management first reported a position in IONS in Q4 2013 and has held it in 46 quarters since. The position peaked at $949K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Northwestern Mutual Wealth Management held 11,123 shares of Ionis Pharmaceuticals worth $835K as of Q1 2026.
- Northwestern Mutual Wealth Management sold 875 Ionis Pharmaceuticals shares in Q1 2026, an estimated $69.1K.
- Ionis Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1405 holding.
- Northwestern Mutual Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 46 quarters since.
- Northwestern Mutual Wealth Management's Ionis Pharmaceuticals position peaked at $949K in Q4 2025.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.